86 related articles for article (PubMed ID: 2332786)
1. In-vitro evaluation of a new oral cephalosporin, cefroxadine (CGP 9000).
Shibl AM; Durgham SM
J Chemother; 1990 Feb; 2(1):8-10. PubMed ID: 2332786
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model.
Schneider P; Tosch W; Maurer M; Zak O
J Antibiot (Tokyo); 1982 Jul; 35(7):843-9. PubMed ID: 7174537
[TBL] [Abstract][Full Text] [Related]
3. Cefroxadine (CGP-9000), an orally active cephalosporin.
Yasuda K; Kurashige S; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jul; 18(1):105-10. PubMed ID: 6998373
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.
Bergan T
Chemotherapy; 1980; 26(4):225-30. PubMed ID: 7389422
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
Motomori R; Takahashi H; Yamamoto J; Yamasaki F
Jpn J Antibiot; 1983 Sep; 36(9):2562-70. PubMed ID: 6655871
[TBL] [Abstract][Full Text] [Related]
6. Comparison of microbiological and high pressure liquid chromatographic assays of the new cephalosporin cefroxadine.
Bergan T; Solberg R
Methods Find Exp Clin Pharmacol; 1981; 3(3):179-82. PubMed ID: 7253774
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effect of cefroxadine on surgical infections].
Aikawa T; Noguchi S; Fujimoto N; Mizushima H; Shibata N; Tomita N; Horii A
Jpn J Antibiot; 1983 Sep; 36(9):2521-8. PubMed ID: 6686263
[TBL] [Abstract][Full Text] [Related]
8. [A study of the disc sensitivity test for cephradine].
Kanazawa Y; Kuramata T; Matsumoto K
Jpn J Antibiot; 1982 Jul; 35(7):1722-9. PubMed ID: 7176072
[TBL] [Abstract][Full Text] [Related]
9. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
Jones RN; Erwin ME
J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of cefroxadine in the field of pediatrics (author's transl)].
Iwai N; Sasaki A; Taneda Y; Inokuma K; Nakamura H
Jpn J Antibiot; 1981 Dec; 34(12):1663-79. PubMed ID: 7334591
[TBL] [Abstract][Full Text] [Related]
11. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental and clinical studies of cefroxadine in pediatric field (author's transl)].
Toyonaga Y; Kurosu Y; Hori M; Kohno S
Jpn J Antibiot; 1981 Dec; 34(12):1608-25. PubMed ID: 7334586
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of cefroxadine in surgical infections].
Hirayama T; Kikuchi K
Jpn J Antibiot; 1983 Jun; 36(6):1435-8. PubMed ID: 6655799
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
Jones RN; Barry AL; Pfaller M; Allen SD; Ayers LW; Fuchs PC
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):59-63. PubMed ID: 3370932
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
Uchida S; Hayashi H; Tominaga M; Kohno K; Matsunaga M; Kudo S; Kawamura R
Jpn J Antibiot; 1983 Sep; 36(9):2549-55. PubMed ID: 6655869
[TBL] [Abstract][Full Text] [Related]
16. CGP 9000: a new orally active, broad-spectrum cephalosporin.
Zak O; Vischer WA; Schenk C; Tosch W; Zimmermann W; Regös J; Suter ER; Kradolfer F; Gelzer J
J Antibiot (Tokyo); 1976 Jun; 29(6):653-5. PubMed ID: 950320
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of cefroxadine dry syrup in pediatric field (author's transl)].
Minamitani M; Hachimori K; Suzuki M; Minamikawa I
Jpn J Antibiot; 1981 Dec; 34(12):1626-33. PubMed ID: 7334587
[TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
[TBL] [Abstract][Full Text] [Related]
19. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
Jones RN; Erwin ME; Gooding BB
J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
[TBL] [Abstract][Full Text] [Related]
20. [Study on the transfer of cefroxadine to human tears].
Hara J; Tanaka Y; Harino S; Deguchi K
Jpn J Antibiot; 1985 Feb; 38(2):230-4. PubMed ID: 4009946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
